Summary & Overview
HCPCS C1767: Implantable Non-Rechargeable Neurostimulator Generator
HCPCS Level II code C1767 designates an implantable, non-rechargeable neurostimulator generator— the implanted power source for neurostimulation systems. This code is relevant nationally for hospitals, ambulatory surgical centers, neurosurgeons, pain specialists, and device manufacturers because it identifies a high-cost durable implantable device used in chronic pain and neurological disorder management. Coverage and reimbursement for C1767 affect access to neuromodulation therapies and facility billing for device implantation.
Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of payer coverage patterns, common site-of-service designations, and typical clinical use cases. The publication summarizes available benchmarks for device reimbursement, highlights policy and coverage considerations that influence utilization, and provides clinical context about when implantable, non-rechargeable generators are used versus alternative devices.
The report is intended for revenue cycle managers, hospital billing teams, clinicians involved in device selection, and policy analysts seeking a national perspective on coding, billing, and coverage issues surrounding implantable neurostimulator generators.
Billing Code Overview
HCPCS Level II code C1767 describes an implantable, non-rechargeable neurostimulator generator used in neuromodulation therapy. This device serves as the power source and pulse generator for an implanted neurostimulation system intended to modulate neural signals for therapeutic effect.
-
Service type: Implantable neurostimulator generator placement and device supply
-
Typical site of service: Inpatient or outpatient surgical settings, including ambulatory surgery centers and hospital operating rooms
Clinical & Coding Specifications
Clinical Context
A 58-year-old patient with chronic, medically refractory neuropathic pain after failed back surgery presents for implantation of a non-rechargeable implantable neurostimulator generator. The patient has tried conservative therapy including medications, physical therapy, and a successful percutaneous trial spinal cord stimulation with significant pain relief. The workflow includes preoperative evaluation (history, medication reconciliation, informed consent, and device selection), intraoperative implantation of the C1767 non-rechargeable neurostimulator generator with connection to leads previously placed or placed in the same procedure, device testing and programming in the operating room, wound closure, and immediate post-anesthesia recovery. Typical site of service is an operating room in an ambulatory surgery center or hospital inpatient/outpatient surgical suite. Postoperative follow-up includes wound check, device programming/adjustment in clinic, and periodic battery-life monitoring and generator replacement planning.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier - standard reporting | Use when no unusual circumstances apply to the service. |
| 22 | Increased procedural services | Use when work required is substantially greater than typical for generator implantation due to extensive dissection or unexpected complexity.